These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27401544)

  • 1. Efficacy of eculizumab against Eosinophilic Fasciitis associated with Paroxysmal Nocturnal Haemoglobinuria.
    Frumholtz L; Sebert M; de Masson A; Attias P; Ades L; Roux J; Jachiet M; Cabannes-Hamy A; Elena Noguera M; Attencourt C; Bagot M; Socié G; Rybojad M; de La Tour RP; Bouaziz JD
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):e101-e102. PubMed ID: 27401544
    [No Abstract]   [Full Text] [Related]  

  • 2. Eosinophilic fasciitis with paroxysmal nocturnal hemoglobinuria.
    de Boysson H; Chèze S; Chapon F; Le Mauff B; Auzary C; Geffray L
    Joint Bone Spine; 2013 Mar; 80(2):208-10. PubMed ID: 22999899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eculizumab therapy in paroxysmal nocturnal haemoglobinuria patient undergoing aortic valve surgery.
    Kusadokoro S; Kimura N; Hori D; Yamaguchi A
    Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):994-995. PubMed ID: 30715380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [With paroxysmal nocturnal haemoglobinuria and treatment with eculizumab].
    Algado JT; Luque R; Nuñez R; Sanchez B
    Enferm Infecc Microbiol Clin; 2012 Feb; 30(2):109-10. PubMed ID: 22197277
    [No Abstract]   [Full Text] [Related]  

  • 5. Disseminated gonococcal infection in a patient with paroxysmal nocturnal haemoglobinuria receiving eculizumab.
    Niitsuma-Sugaya I; Kanamori H; Ichikawa S; Fukuhara N; Seike I; Takei K; Baba H; Oshima K; Aoyagi T; Harigae H; Tokuda K
    Lancet Infect Dis; 2021 May; 21(5):741. PubMed ID: 33894850
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab.
    van Bijnen ST; van Rijn RS; Koljenovic S; te Boekhorst P; de Witte T; Muus P
    Br J Haematol; 2012 Jun; 157(6):762-3. PubMed ID: 22372429
    [No Abstract]   [Full Text] [Related]  

  • 7. Infections during eculizumab therapy in a Dutch population of patients with paroxysmal nocturnal haemoglobinuria.
    Schaap CCM; Grotens A; de Haan AFJ; Blijlevens NMA; Langemeijer SMC
    Clin Microbiol Infect; 2021 Oct; 27(10):1534-1536. PubMed ID: 34197930
    [No Abstract]   [Full Text] [Related]  

  • 8. Hereditary Hemochromatosis Manifesting After Treatment of Paroxysmal Nocturnal Hemoglobinuria With Eculizumab.
    Elliott E; Waheed S; Syed S; Eswaran S; Gregory S; Shammo J
    Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):e9-e12. PubMed ID: 29102415
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rare case of a pregnancy in a woman with paroxysmal nocturnal hemoglobinuria. Case report].
    Horányi D; Várkonyi A; Nagy GR; Bodó I; Masszi T
    Orv Hetil; 2016 Jun; 157(23):916-8; quiz 919-20. PubMed ID: 27233835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cascade of thromboembolic processes in a patient with paroxysmal nocturnal haemoglobinuria terminated by treatment with eculizumab.
    Schutgens RE; Pruissen-Peeters KA; Muus P
    Thromb Haemost; 2011 Aug; 106(2):383-5. PubMed ID: 21655680
    [No Abstract]   [Full Text] [Related]  

  • 11. [Successful eculizumab treatment for multiple coronary thrombosis complicated in paroxysmal nocturnal hemoglobinuria].
    Taniguchi A; Ikezoe T; Takeuchi A; Togitani K; Yoshimoto M; Tanioka K; Kitaoka H; Yokoyama A
    Rinsho Ketsueki; 2014 Aug; 55(8):965-9. PubMed ID: 25186487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging.
    Risitano AM; Imbriaco M; Marando L; Seneca E; Soscia E; Malcovati L; Iori AP; Pane F; Notaro R; Matarazzo M
    Br J Haematol; 2012 Aug; 158(3):415-8. PubMed ID: 22571809
    [No Abstract]   [Full Text] [Related]  

  • 13. Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria.
    Keating GM; Lyseng-Williamson KA; McKeage K
    BioDrugs; 2012 Apr; 26(2):125-30. PubMed ID: 22350448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durable resolution of recurrent microvascular small bowel ischaemia and severe abdominal pain by eculizumab in paroxysmal nocturnal haemoglobinuria.
    Grigg A; Brown M; Szer J
    Intern Med J; 2010 Nov; 40(11):794-5. PubMed ID: 21108715
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapidly evolving skin manifestations due to progressive thrombosis in a patient with paroxysmal nocturnal haemoglobinuria resolved with prompt initiation of eculizumab.
    Otters EF; Zarafonitis G; Steenbergen EJ; van der Valk PG; Muus P
    Br J Dermatol; 2014 Oct; 171(4):908-10. PubMed ID: 24701978
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab.
    Darnige L; Peffault de Latour R; Zemori L; Socié G; Fischer AM; Helley D;
    Br J Haematol; 2011 Jun; 153(6):789-91. PubMed ID: 21457219
    [No Abstract]   [Full Text] [Related]  

  • 17. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Takita M; Matsumura T; Kami M
    N Engl J Med; 2006 Dec; 355(26):2787; author reply 2787-8. PubMed ID: 17193722
    [No Abstract]   [Full Text] [Related]  

  • 18. AOHE: manuscript AOHE-D-16-00564 paroxysmal nocturnal hemoglobinuria with autoimmune hemolytic anemia following eculizumab therapy-with large granular lymphocytic leukemia.
    Visweshwar N; Jaglal M; Booth C; Griffin P; Laber D
    Ann Hematol; 2016 Oct; 95(10):1747-9. PubMed ID: 27449072
    [No Abstract]   [Full Text] [Related]  

  • 19. An unusual presentation of paroxysmal nocturnal haemoglobinuria.
    Sanchez-Petitto G; Drachenberg CB; Mannuel HD; Law JY; Zimrin AB; Baer MR
    Br J Haematol; 2020 Feb; 188(3):347. PubMed ID: 31750542
    [No Abstract]   [Full Text] [Related]  

  • 20. Eculizumab (Soliris) and paroxysmal nocturnal haemoglobinuria in children. When transfusions are too frequent.
    Prescrire Int; 2015 May; 24(160):121. PubMed ID: 26034803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.